BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Konrad T, Zeuzem S, Vicini P, Toffolo G, Briem D, Lormann J, Herrmann G, Berger A, Kusterer K, Teuber G. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha. Eur J Clin Invest. 2000;30:111-121. [PMID: 10651835 DOI: 10.1046/j.1365-2362.2000.00608.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Strauhs-Nitsch L, Campiolo MF, Morsoletto DBG, Pissaia Junior A, Ivantes CAP. CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEAR. Arq Gastroenterol 2020;57:267-71. [PMID: 33027477 DOI: 10.1590/S0004-2803.202000000-50] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Carvalho JR, Velosa J, Serejo F. Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication - comparison of the new direct-acting antiviral agents with the old regimens. Scand J Gastroenterol. 2018;53:857-863. [PMID: 29779403 DOI: 10.1080/00365521.2018.1473486] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
3 Singhal A, Agrawal A, Ling J. Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs. J Cell Mol Med 2018;22:2071-85. [PMID: 29411512 DOI: 10.1111/jcmm.13553] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Fabrizi F, Messa P, Martin P, Takkouche B. Hepatitis C Virus Infection and Post-Transplant Diabetes Mellitus among Renal Transplant Patients: A Meta-Analysis. Int J Artif Organs 2008;31:675-82. [DOI: 10.1177/039139880803100801] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
5 Desbois AC, Cacoub P. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World J Gastroenterol 2017; 23(9): 1697-1711 [PMID: 28321170 DOI: 10.3748/wjg.v23.i9.1697] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 53] [Article Influence: 12.2] [Reference Citation Analysis]
6 Zignego AL, Ramos-Casals M, Ferri C, Saadoun D, Arcaini L, Roccatello D, Antonelli A, Desbois AC, Comarmond C, Gragnani L, Casato M, Lamprecht P, Mangia A, Tzioufas AG, Younossi ZM, Cacoub P; ISG-EHCV. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmun Rev. 2017;16:523-541. [PMID: 28286108 DOI: 10.1016/j.autrev.2017.03.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 60] [Article Influence: 10.4] [Reference Citation Analysis]
7 Ferri C, Ramos-Casals M, Zignego AL, Arcaini L, Roccatello D, Antonelli A, Saadoun D, Desbois AC, Sebastiani M, Casato M. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmun Rev. 2016;15:1145-1160. [PMID: 27640316 DOI: 10.1016/j.autrev.2016.09.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 10.5] [Reference Citation Analysis]
8 Sawinski D, Bloom RD. Novel Hepatitis C Treatment and the Impact on Kidney Transplantation. Transplantation. 2015;99:2458-2466. [PMID: 26214816 DOI: 10.1097/tp.0000000000000847] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
9 Kralj D, Virović Jukić L, Stojsavljević S, Duvnjak M, Smolić M, Čurčić IB. Hepatitis C Virus, Insulin Resistance, and Steatosis. J Clin Transl Hepatol 2016;4:66-75. [PMID: 27047774 DOI: 10.14218/JCTH.2015.00051] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 9.5] [Reference Citation Analysis]
10 Vallet-Pichard A, Pol S. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure]. Nephrol Ther 2015;11:507-20. [PMID: 26423779 DOI: 10.1016/j.nephro.2015.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Li DW, Lu TF, Hua XW, Dai HJ, Cui XL, Zhang JJ, Xia Q. Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. World J Gastroenterol 2015; 21(20): 6329-6340 [PMID: 26034369 DOI: 10.3748/wjg.v21.i20.6329] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
12 Antonelli A, Ferrari SM, Giuggioli D, Di Domenicantonio A, Ruffilli I, Corrado A, Fabiani S, Marchi S, Ferri C, Ferrannini E, Fallahi P. Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes 2014; 5(5): 586-600 [PMID: 25317237 DOI: 10.4239/wjd.v5.i5.586] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 56] [Article Influence: 7.8] [Reference Citation Analysis]
13 Murdolo G, Francisci D, Forini F, Baldelli F, Angeletti G, Stagni G, Santeusanio F, Calcinaro F, Falorni A. Expression of endocrine autoantibodies in chronic hepatitis C, before and after interferon-α therapy. J Endocrinol Invest 2002;25:938-46. [DOI: 10.1007/bf03344065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
14 Pisonero-Vaquero S, García-Mediavilla MV, Jorquera F, Majano PL, Benet M, Jover R, González-Gallego J, Sánchez-Campos S. Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin. Lab Invest 2014;94:262-74. [PMID: 24492281 DOI: 10.1038/labinvest.2013.156] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
15 Babudieri S, Soddu A, Nieddu P, Tanca A, Madeddu G, Addis M, Pagnozzi D, Cossu-rocca P, Massarelli G, Dore M, Uzzau S, Mura M. Proteomic characterization of hepatitis C eradication: Enzyme switch in the healing liver. Journal of Clinical Virology 2013;57:274-8. [DOI: 10.1016/j.jcv.2013.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Kamar N, Alric L, Izopet J, Rostaing L. Hepatitis C virus and kidney disease. Clin Res Hepatol Gastroenterol. 2013;37:328-333. [PMID: 23522570 DOI: 10.1016/j.clinre.2013.02.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
17 Ibrahim MA, Sany D, El Shahawy Y, Awdallah A. Effect of activated vitamin D on glucoparameters in HCV seropositive and seronegative patients on chronic hemodialysis. Ren Fail 2012;34:1188-94. [PMID: 22871095 DOI: 10.3109/0886022X.2012.706877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Hassan M, Selimovic D, El-Khattouti A, Ghozlan H, Haikel Y, Abdelkader O. Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World J Exp Med 2012; 2(2): 7-25 [PMID: 24520529 DOI: 10.5493/wjem.v2.i2.7] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Wiśniewska-Ligier M, Konopka A, Woźniakowska-Gęsicka T. Lipid and carbohydrate parameters in children with chronic hepatitis C. Adv Med Sci 2011;56:180-5. [PMID: 22112430 DOI: 10.2478/v10039-011-0048-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Jadoon NA, Shahzad MA, Yaqoob R, Hussain M, Ali N. Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association. Virol J. 2010;7:304. [PMID: 21054842 DOI: 10.1186/1743-422x-7-304] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
21 Cross TJS, Rashid MM, Berry PA, Harrison PM. The importance of steatosis in chronic hepatitis C infection and its management: A review. Hepatology Research 2010;40:237-47. [DOI: 10.1111/j.1872-034x.2010.00626.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
22 Montano-Loza AJ, Sultan A, Falanga D, Loss G, Mason AL. Immunogenetic susceptibility to diabetes mellitus in patients with liver disease. Liver Int 2009;29:1543-51. [PMID: 19663932 DOI: 10.1111/j.1478-3231.2009.02095.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
23 Nwankiti OO, Ndako JA, Echeonwu GO, Olabode AO, Nwosuh CI, Onovoh EM, Okeke LA, Akinola JO, Duru BN, Nwagbo IO, Agada GO, Chukwuedo AA. Hepatitis C Virus infection in apparentenly healthy individuals with family history of diabetes in Vom, Plateau State Nigeria. Virol J 2009;6:110. [PMID: 19619316 DOI: 10.1186/1743-422X-6-110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
24 Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI. Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance. Gut Liver. 2009;3:108-115. [PMID: 20431732 DOI: 10.5009/gnl.2009.3.2.108] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
25 Bloom RD, Crutchlow MF. Transplant-associated hyperglycemia. Transplant Rev (Orlando). 2008;22:39-51. [PMID: 18631857 DOI: 10.1016/j.trre.2007.06.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
26 Lv YY, Shi BY, Guo H. Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B. World J Gastroenterol 2008; 14(29): 4713-4715 [PMID: 18698691 DOI: 10.3748/wjg.14.4713] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
27 . Guideline 3: Preventing HCV transmission in hemodialysis units. Kidney International 2008;73:S46-52. [DOI: 10.1038/ki.2008.86] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
28 . Guideline 4: Management of HCV-infected patients before and after kidney transplantation. Kidney International 2008;73:S53-68. [DOI: 10.1038/ki.2008.87] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
29 . Guideline 2: Treatment of HCV infection in patients with CKD. Kidney International 2008;73:S20-45. [DOI: 10.1038/ki.2008.85] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
30 . Introduction. Kidney International 2008;73:S6-9. [DOI: 10.1038/ki.2008.83] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Hora C, Negro F, Leandro G, Oneta CM, Rubbia-brandt L, Muellhaupt B, Helbling B, Malinverni R, Gonvers J, Dufour J; the Swiss Hepatitis C Cohort Study Group. Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C: CTGF, steatosis and hepatitis C. Liver International 2008;28:370-6. [DOI: 10.1111/j.1478-3231.2007.01608.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
32 Björnsson E, Angulo P. Hepatitis C and steatosis. Arch Med Res. 2007;38:621-627. [PMID: 17613353 DOI: 10.1016/j.arcmed.2006.09.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
33 Tosone G, Borgia G, Gentile I, Cerini R, Conte MC, Orlando R, Piazza M. A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided? Acta Diabetol 2007;44:167-9. [PMID: 17721757 DOI: 10.1007/s00592-007-0259-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
34 Svegliati-Baroni G, Bugianesi E, Bouserhal T, Marini F, Ridolfi F, Tarsetti F, Ancarani F, Petrelli E, Peruzzi E, Lo Cascio M, Rizzetto M, Marchesini G, Benedetti A. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. Gut 2007;56:1296-301. [PMID: 17392334 DOI: 10.1136/gut.2006.107946] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
35 Soultati AS, Dourakis SP, Alexopoulou A, Deutsch M, Archimandritis AJ. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C. World J Gastroenterol 2007; 13(8): 1292-1294 [PMID: 17451219 DOI: 10.3748/wjg.v13.i8.1292] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
36 Crutchlow MF, Bloom RD. Transplant-associated hyperglycemia: a new look at an old problem. Clin J Am Soc Nephrol. 2007;2:343-355. [PMID: 17699434 DOI: 10.2215/cjn.03671106] [Cited by in Crossref: 70] [Cited by in F6Publishing: 50] [Article Influence: 4.7] [Reference Citation Analysis]
37 Puri P, Sanyal AJ. Role of Obesity, Insulin Resistance, and Steatosis in Hepatitis C Virus Infection. Clinics in Liver Disease 2006;10:793-819. [DOI: 10.1016/j.cld.2006.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Stockmann M, Konrad T, Nolting S, Hünerbein D, Wernecke KD, Döbling H, Steinmüller T, Neuhaus P. Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation. Liver Transpl. 2006;12:535-543. [PMID: 16496277 DOI: 10.1002/lt.20633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
39 Negro F. Insulin resistance and HCV: will new knowledge modify clinical management? J Hepatol 2006;45:514-9. [PMID: 16901576 DOI: 10.1016/j.jhep.2006.07.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
40 Noto H, Raskin P. Hepatitis C infection and diabetes. J Diabetes Complications. 2006;20:113-120. [PMID: 16504840 DOI: 10.1016/j.jdiacomp.2006.01.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
41 Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant. 2005;5:2433-2440. [PMID: 16162192 DOI: 10.1111/j.1600-6143.2005.01040.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 9.4] [Reference Citation Analysis]
42 Harrison SA. Liver Disease in Patients With Diabetes Mellitus. Journal of Clinical Gastroenterology 2006;40:68-76. [DOI: 10.1097/01.mcg.0000190774.91875.d2] [Cited by in Crossref: 124] [Cited by in F6Publishing: 116] [Article Influence: 7.8] [Reference Citation Analysis]
43 Bugianesi E, Marchesini G. Reply:. Hepatology 2006;43:1168-9. [DOI: 10.1002/hep.21195] [Reference Citation Analysis]
44 Zekry A, McHutchison JG, Diehl AM. Insulin resistance and steatosis in hepatitis C virus infection. Gut 2005;54:903-6. [PMID: 15951532 DOI: 10.1136/gut.2004.059873] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
45 Visnegarwala F, Chen L, Raghavan S, Tedaldi E. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. J Infect. 2005;50:331-337. [PMID: 15845431 DOI: 10.1016/j.jinf.2004.06.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
46 Stockmann M, Nolting S, Konrad T, Hünerbein D, Döbling H, Steinmüller T, Neuhaus P. No influence of immunosuppression on insulin sensitivity and beta-cell function in living donor liver transplantation. Transplant Proc 2005;37:1861-4. [PMID: 15919486 DOI: 10.1016/j.transproceed.2005.02.093] [Reference Citation Analysis]
47 Narita R, Abe S, Kihara Y, Akiyama T, Tabaru A, Otsuki M. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol 2004;41:132-8. [PMID: 15246219 DOI: 10.1016/j.jhep.2004.03.020] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 3.5] [Reference Citation Analysis]
48 Liangpunsakul S, Chalasani N. Relationship between hepatitis C and microalbuminuria: Results from the NHANES III. Kidney International 2005;67:285-90. [DOI: 10.1111/j.1523-1755.2005.00080.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
49 Ratziu V, Munteanu M, Charlotte F, Bonyhay L, Poynard T; LIDO Study Group. Fibrogenic impact of high serum glucose in chronic hepatitis C. J Hepatol. 2003;39:1049-1055. [PMID: 14642625 DOI: 10.1016/s0168-8278(03)00456-2] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 6.4] [Reference Citation Analysis]
50 Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y, Schattner A. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol. 2003;98:2751-2756. [PMID: 14687828 DOI: 10.1111/j.1572-0241.2003.08728.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 75] [Article Influence: 2.4] [Reference Citation Analysis]
51 Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology. 2003;125:1695-1704. [PMID: 14724822 DOI: 10.1053/j.gastro.2003.08.032] [Cited by in Crossref: 503] [Cited by in F6Publishing: 488] [Article Influence: 27.9] [Reference Citation Analysis]
52 Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C. Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther 2003;18:549-58. [PMID: 12969081 DOI: 10.1046/j.1365-2036.2003.01681.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
53 Gentil M, López M, González-roncero F, Rodríguez-algarra G, Pereira P, López R, Martínez M, Toro J, Mateos J. Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols. Transplantation Proceedings 2003;35:1748-50. [DOI: 10.1016/s0041-1345(03)00611-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
54 Friedenberg F, Pungpapong S, Zaeri N, Braitman LE. The impact of diabetes and obesity on liver histology in patients with hepatitis C. Diabetes Obes Metab 2003;5:150-5. [PMID: 12681021 DOI: 10.1046/j.1463-1326.2003.00256.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
55 Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci. 2003;325:135-148. [PMID: 12640289 DOI: 10.1097/00000441-200303000-00006] [Cited by in Crossref: 94] [Cited by in F6Publishing: 84] [Article Influence: 4.9] [Reference Citation Analysis]
56 Mason A, Nair S. Is type II diabetes another extrahepatic manifestation of HCV infection? Am J Gastroenterol 2003;98:243-6. [PMID: 12591036 DOI: 10.1111/j.1572-0241.2003.07269.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
57 Mofredj A, Howaizi M, Grasset D, Licht H, Loison S, Devergie B, Demontis R, Cadranel JF. Diabetes mellitus during interferon therapy for chronic viral hepatitis. Dig Dis Sci. 2002;47:1649-1654. [PMID: 12141831 DOI: 10.1023/A:1015852110353] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
58 Recasens M, Aguilera E, Ampurdanés S, Sánchez Tapias JM, Simó O, Casamitjana R, Conget I. Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C. Diabet Med. 2001;18:764-767. [PMID: 11606177 DOI: 10.1046/j.1464-5491.2001.00562.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
59 Mason A. Viral Induction of Type 2 Diabetes and Autoimmune Liver Disease. The Journal of Nutrition 2001;131:2805S-8S. [DOI: 10.1093/jn/131.10.2805s] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
60 Everhart J. A confluence of epidemics: does hepatitis C cause type 2 diabetes? Hepatology 2001;33:762-3. [PMID: 11230760 DOI: 10.1002/hep.510330336] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]